Rapid, Sensitive Detection of Protein Biomarkers in Minimally‐Processed Blood Products with a Monolithic Sandwich Immunoassay Reagent

N Nicolò Maganzini (Department of Electrical Engineering Stanford University Stanford CA 94305 USA) A Agnes Reschke (Department of Pediatric Critical Care Stanford University Stanford CA 94305 USA) A Alyssa P. Cartwright (Department of Electrical Engineering Stanford University Stanford CA 94305 USA) Y Yasser Gidi (Department of Electrical Engineering Stanford University Stanford CA 94305 USA) I Ian Andrew Paul Thompson (Department of Electrical Engineering Stanford University Stanford CA 94305 USA) S Steven Yee (Department of Electrical Engineering Stanford University Stanford CA 94305 USA) A Amani Hariri (Department of Electrical Engineering Stanford University Stanford CA 94305 USA) C Constantin Dory (Department of Electrical Engineering Stanford University Stanford CA 94305 USA) Y Yael Rosenberg‐Hasson (Human Immune Monitoring Center Stanford University Stanford CA 94305 USA) J Jing Pan M Michael Eisenstein J Jelena Vučković (E. L. Ginzton Laboratory, Stanford University) T Timothy Thomas Cornell (Department of Pediatric Critical Care Stanford University Stanford CA 94305 USA) H Hyongsok Tom Soh

Abstract

AbstractFor more than fifty years, the enzyme‐linked immunosorbent assay (ELISA) serves as the gold standard for protein biomarker detection. However, conventional ELISA requires considerable sample preparation including reagent addition, incubation, and washing steps, limiting its usefulness at the point‐of‐care. In this work, the “instant ELISA” (fluorophore‐linked immunosorbent assay) biosensor that can measure protein biomarkers in the picomolar range within 15 min in undiluted plasma or serum with no sample preparation is described. The sensor leverages a synthetic reagent termed the “monolithic dual‐antibody clamp” (MDAC) which preserves the specificity, sensitivity, and generalizability of an ELISA, but produces a fluorescence signal as two surface‐tethered antibodies form a “sandwich” by binding to two distinct epitopes on the target. As exemplars, picomolar quantification of tumor necrosis factor alpha (TNFα) and monocyte chemotactic protein (MCP)‐1, the latter of which is a useful prognostic indicator of cytokine release syndrome in patient plasma samples during chimeric antigen receptor T cell therapy are demonstrated.

Article Details

Volume / Issue Vol. 37, Issue 11
Published March 01, 2025
ISSN 0935-9648
Publisher Unknown Publisher

Journal Info

Advanced Materials

Unknown Publisher

ISSN: 0935-9648 Physical Sciences

Authors (14)

N

Nicolò Maganzini

Department of Electrical Engineering Stanford University Stanford CA 94305 USA

A

Agnes Reschke

Department of Pediatric Critical Care Stanford University Stanford CA 94305 USA

A

Alyssa P. Cartwright

Department of Electrical Engineering Stanford University Stanford CA 94305 USA

Y

Yasser Gidi

Department of Electrical Engineering Stanford University Stanford CA 94305 USA

I

Ian Andrew Paul Thompson

Department of Electrical Engineering Stanford University Stanford CA 94305 USA

S

Steven Yee

Department of Electrical Engineering Stanford University Stanford CA 94305 USA

A

Amani Hariri

Department of Electrical Engineering Stanford University Stanford CA 94305 USA

C

Constantin Dory

Department of Electrical Engineering Stanford University Stanford CA 94305 USA

Y

Yael Rosenberg‐Hasson

Human Immune Monitoring Center Stanford University Stanford CA 94305 USA

J

Jing Pan

M

Michael Eisenstein

J

Jelena Vučković

E. L. Ginzton Laboratory, Stanford University

T

Timothy Thomas Cornell

Department of Pediatric Critical Care Stanford University Stanford CA 94305 USA

H

Hyongsok Tom Soh